Understanding early psychosis through biomarkers and specialized care
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)
This study is looking at how certain biological signs and symptoms can help us understand and predict how young adults with early psychosis, like schizophrenia or bipolar disorder, will do over time, so we can create better treatment plans just for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10880351 on NIH RePORTER |
What this research studies
This research investigates how biomarkers and clinical features can help predict the outcomes of early psychosis in young adults. By analyzing data from patients aged 18-35 with conditions like schizophrenia and bipolar disorder, the study aims to categorize patients into different biotypes based on their symptoms and biological markers. This categorization will help tailor treatment plans and improve the effectiveness of coordinated specialty care services. Patients will be followed up at 1, 6, and 12 months to assess their progress and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 18-35 who are experiencing early symptoms of psychosis, including those with schizophrenia or bipolar disorder.
Not a fit: Patients outside the age range of 18-35 or those not experiencing early psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for individuals experiencing early psychosis.
How similar studies have performed: Previous research has shown promise in using biomarkers for predicting outcomes in psychosis, suggesting that this approach could be effective.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Keshavan, Matcheri S. — Beth Israel Deaconess Medical Center
- Study coordinator: Keshavan, Matcheri S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.